The Genome Project Holds Promise, But We Must Look Before We Leap

To an ever-increasing degree, explanation in biology is reduced to art expression in the language of DNA sequences. At least, a necessary condition for the interpretation of many problems in evolution, genetics, virology, immunology teratology, or cancer is the elucidation of a message in the well-known ATGC alphabet. Furthermore, the power of biotechnology rests on manufacturing blueprints of the same ilk. To a degree " unprecedented in biological history, we can describe the agenda for much

Written byJoshua Lederberg
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

To an ever-increasing degree, explanation in biology is reduced to art expression in the language of DNA sequences. At least, a necessary condition for the interpretation of many problems in evolution, genetics, virology, immunology teratology, or cancer is the elucidation of a message in the well-known ATGC alphabet. Furthermore, the power of biotechnology rests on manufacturing blueprints of the same ilk. To a degree " unprecedented in biological history, we can describe the agenda for much of the programmable research for several decades to come. It is undeniable that a full catalog of a human DNA sequence would be a great convenience in the solution of problems pertaining to particular segments. There isthen great merit in the prospect, and I would share the excitement of achievement in a host of steps toward that goal. In particular, we should certainly encourage investigators who seek to apply individual intelligence to that end. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies